Pulmonary Function Testing Systems Market to Register 6.6% CAGR Through 2031 Amid Portable Diagnostics Boom

United States of America – December 30, 2025 – According to The Insight Partners, the pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028. Pulmonary function testing systems continue to transform respiratory diagnostics, empowering clinicians worldwide to detect and manage lung conditions more effectively amid rising global awareness of chronic respiratory diseases. Healthcare providers increasingly rely on these advanced pulmonary function testing systems to deliver precise, patient-centered care in hospitals, clinics, and even home settings.​

Get a Sample Copy At - https://www.theinsightpartners.com/sample/TIPRE00017822/

Industry leaders like SCHILLER, COSMED srl, and MGC Diagnostics Corporation lead the charge with cutting-edge pulmonary function testing systems that blend portability, software enhancements, and seamless data integration. Recent developments highlight how these pulmonary function testing systems evolve to meet demands for faster spirometry results and comprehensive lung volume assessments.​

Market Momentum

Pulmonary function testing systems have gained traction due to growing needs for early detection of conditions like chronic obstructive pulmonary disorder (COPD), asthma, and restrictive lung disease. Portable and cart-based pulmonary function testing systems now dominate, offering flexibility for diverse clinical environments from busy urban hospitals to remote rural clinics. Recent FDA approvals for innovative pulmonary function testing systems underscore a commitment to non-invasive, real-time monitoring that improves patient outcomes.​

Technological leaps, including AI-driven analysis in pulmonary function testing systems, automate gas exchange testing and oxygen titration processes, reducing diagnostic times significantly. Companies such as ndd Medical Technologies and Vyaire Medical, Inc. push boundaries with user-friendly interfaces that make spirometry and maximum voluntary ventilation tests accessible to a broader range of healthcare professionals. This shift not only streamlines workflows but also enhances accuracy in chronic shortness of breath evaluations.​

The integration of telehealth-compatible pulmonary function testing systems marks a pivotal trend, enabling remote consultations that bridge gaps in underserved regions. As air quality concerns and post-pandemic respiratory vigilance persist, demand surges for reliable pulmonary function testing systems equipped with robust hardware, intuitive software, and comprehensive services.​

Updated Industry News

Breakthroughs in pulmonary function testing systems captured headlines throughout 2025, with MGC Diagnostics Corporation launching a new portable device tailored for enhanced mobility in clinical settings. This innovation addresses key pain points in traditional stationary pulmonary function testing systems by prioritizing ease of use and rapid deployment.​

Global Market Insights reported robust U.S. growth in pulmonary function testing systems, fueled by expanded healthcare infrastructure and heightened focus on occupational lung health screening. Meanwhile, Allied Market Research highlighted Asia-Pacific's rapid ascent, driven by rising chronic disease prevalence in nations like India and China.​

CHEST M.I., Inc. and Pulm One Advanced Medical Devices Ltd introduced software upgrades for pulmonary function testing systems, incorporating machine learning for predictive analytics in lung volume measurements. These updates align with broader industry shifts toward digital health solutions, including IoT-enabled pulmonary function testing systems for continuous monitoring.​

Key Segments

Pulmonary function testing systems span diverse categories tailored to specific clinical needs.

• By Type: Cart-based pulmonary function testing systems offer comprehensive stationary setups ideal for high-volume hospital labs, while portable variants excel in outpatient and field applications.
• By Test Type: Spirometry leads for quick airflow assessments, complemented by lung volume, gas exchange testing, maximum voluntary ventilation, and oxygen titration tests for detailed diagnostics.
• By Component: Hardware forms the backbone with durable sensors, software provides actionable insights through data visualization, and services ensure ongoing calibration and training.
• By Application: Systems target chronic obstructive pulmonary disorder, asthma, chronic shortness of breath, and restrictive lung disease, enabling personalized treatment pathways.

Market leaders including Ganshorn Medizin Electronic, Morgan Scientific Inc., and COSMED srl dominate with specialized pulmonary function testing systems that integrate seamlessly across these segments.

Global and Regional Analysis

North America commands a leading position in pulmonary function testing systems adoption, bolstered by advanced healthcare spending and key players like MGC Diagnostics Corporation. Europe follows closely, with firms such as SCHILLER driving spirometry innovations amid stringent regulatory standards.​

Asia-Pacific emerges as the fastest-growing region for pulmonary function testing systems, propelled by urbanization, pollution-related respiratory issues, and expanding geriatric populations in India and China. Latin America and the Middle East & Africa show promise through rising investments in diagnostic infrastructure.​

Market Size, Share, Trends, Analysis, and Forecast by 2031

• Global Market Size: Pulmonary function testing systems projected to expand significantly from current valuations, reaching substantial growth by 2031 amid rising respiratory disease burdens.​
• Market Share: Spirometry and portable systems hold dominant shares; North America leads regionally at over 40%, with Asia-Pacific gaining rapidly.​
• Key Trends: Portable/handheld pulmonary function testing systems surge with AI, IoT, and telehealth integration; emphasis on home-care and occupational screening grows.​
• Market Analysis: COPD and asthma applications drive demand; software/services segments accelerate due to digital analytics needs; hardware evolves for precision.​
• Forecast to 2031: Steady CAGRs expected through 2031, with Asia-Pacific at highest growth; innovations in gas exchange and lung volume testing fuel expansion.​

Leadership Spotlight

SCHILLER pioneers complete pulmonary function testing systems with ergonomic designs for spirometry and beyond. COSMED srl excels in research-grade pulmonary function testing systems for elite athletic and clinical use. MGC Diagnostics Corporation focuses on user-centric innovations, while ndd Medical Technologies emphasizes affordability in portable pulmonary function testing systems.​

Ganshorn Medizin Electronic and Morgan Scientific Inc. advance gas exchange capabilities, and Pulm One Advanced Medical Devices Ltd targets emerging markets with cost-effective solutions. CHEST M.I., Inc. and Vyaire Medical, Inc. round out the field with service-backed hardware that ensures long-term reliability.

Purchasing This Report? Click Here At - https://www.theinsightpartners.com/buy/TIPRE00017822/

If you have any special requirements about this Pulmonary Function Testing Systems Market report, please let us know and we can provide custom report.

Forward Outlook

Pulmonary function testing systems stand at the forefront of respiratory health evolution, where precision meets accessibility to combat global challenges like COPD and asthma. As providers adopt hybrid models blending stationary power with portable agility, patients benefit from timely interventions that truly breathe new life into care. Stakeholders eye 2031 with optimism, ready to scale pulmonary function testing systems amid technological and demographic tailwinds.

Related Reports

• PFT Systems Market Analysis, Regional and Competitive Landscape Forecast by 2034
• Respiratory Ventilator Tester Market Share and Forecast by 2031
• Spirometer Market Growth and Forecast by 2028
• In Vitro Lung Models Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)
• Spirometer Transducers Market Analysis, Size, Share, Trends, and Forecast by 2034

About The Insight Partners

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in: 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch